ID: ALA3349165

Max Phase: Preclinical

Molecular Formula: C20H30N2O2

Molecular Weight: 330.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](C(N)=O)CC[C@H]4[C@@H]3CC[C@@H]12

Standard InChI:  InChI=1S/C20H30N2O2/c1-19-10-8-14-12(13(19)5-6-15(19)18(21)24)4-7-16-20(14,2)11-9-17(23)22(16)3/h9,11-16H,4-8,10H2,1-3H3,(H2,21,24)/t12-,13-,14-,15+,16+,19-,20+/m0/s1

Standard InChI Key:  HICJAZWBDFYTCP-ALHYADCGSA-N

Associated Targets(Human)

Steroid 5-alpha-reductase 2 937 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Androgen Receptor 5522 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 330.47Molecular Weight (Monoisotopic): 330.2307AlogP: 2.73#Rotatable Bonds: 1
Polar Surface Area: 63.40Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.02CX LogD: 2.02
Aromatic Rings: 0Heavy Atoms: 24QED Weighted: 0.80Np Likeness Score: 1.83

References

1. Rasmusson GH, Reynolds GF, Steinberg NG, Walton E, Patel GF, Liang T, Cascieri MA, Cheung AH, Brooks JR, Berman C..  (1986)  Azasteroids: structure-activity relationships for inhibition of 5 alpha-reductase and of androgen receptor binding.,  29  (11): [PMID:3783591] [10.1021/jm00161a028]

Source